MedaSystems is the leading SaaS platform for Expanded Access (EA) and Investigator-Initiated Studies (IIS), modernizing pre-approval access pathways through its AI-driven workflow platform. It helps pharmaceutical companies and healthcare providers efficiently manage requests, improve patient access, and capture real-world data (RWD) to support evidence generation and regulatory submissions.
Market
Pharmaceutical Companies and Healthcare Providers
Location
Menlo Park,
California,
USA
Coinvestors
Debiopharm Innovation Fund, Nina Capital, Young Sohn